Cost–Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand
2022 · Advances in Therapy · 23 citations
https://doi.org/10.1007/s12325-021-02037-6
K
Kriengsak Vareesangthip
Siriraj Hospital(TH)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
56
Papers
1.1K
Citations
17
h-index
22
i10-index
Kriengsak Vareesangthip is an academic researcher from Siriraj Hospital. The author has contributed to research in topics: Dialysis and Renal Disease Management & Genetic and Kidney Cyst Diseases & Renal Diseases and Glomerulopathies. The author has an h-index of 17, co-authored 48 publications.
ORCID: 0000-0002-8750-8071Papers by this author
worksInterventional nephrology and vascular access practice: A perspective from South and Southeast Asia
2021 · The Journal of Vascular Access · 22 citations
https://doi.org/10.1177/11297298211011375
Economic evaluation of peritoneal dialysis and hemodialysis in Thai population with End-stage Kidney Disease
2022 · BMC Health Services Research · 19 citations
https://doi.org/10.1186/s12913-022-08827-0
Cost–Utility Analysis of Dapagliflozin as an Add-On to Standard Treatment for Patients with Type 2 Diabetes and High Risk of Cardiovascular Disease in Thailand
2021 · Diabetes Therapy · 9 citations
https://doi.org/10.1007/s13300-021-01088-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat